Regencell Bioscience Holdings (Regencell Bioscience Holdings) Total Assets : $12.62 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Total Assets?

Regencell Bioscience Holdings's Total Assets for the quarter that ended in Jun. 2023 was $12.62 Mil.

During the past 12 months, Regencell Bioscience Holdings's average Total Assets Growth Rate was -34.00% per year. During the past 3 years, the average Total Assets Growth Rate was 102.70% per year.

During the past 5 years, Regencell Bioscience Holdings's highest 3-Year average Total Assets Growth Rate was 102.70%. The lowest was 102.70%. And the median was 102.70%.

Total Assets is connected with ROA %. Regencell Bioscience Holdings's annualized ROA % for the quarter that ended in Jun. 2023 was -37.54%. Total Assets is also linked to Revenue through Asset Turnover. Regencell Bioscience Holdings's Asset Turnover for the quarter that ended in Jun. 2023 was 0.00.

Regencell Bioscience Holdings Total Assets Historical Data

The historical data trend for Regencell Bioscience Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Total Assets Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Total Assets

0.24

0.51

0.34

18.02

12.62

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Assets	Get a 7-Day Free Trial				0.34	21.06	18.02	15.55	12.62

Regencell Bioscience Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Regencell Bioscience Holdings's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	11.989	+	0.632
	=	12.62

Regencell Bioscience Holdings's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2023 )	+	Total Liabilities (Q: Jun. 2023 )
	=	11.989	+	0.632
	=	12.62

Regencell Bioscience Holdings (NAS:RGC) Total Assets Explanation

Total Assets is connected with ROA %.

Regencell Bioscience Holdings's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %	=	Net Income (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	-5.288	/	( (15.548	+	12.622)	/ 2 )
	=	-5.288	/	14.085
	=	-37.54 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Regencell Bioscience Holdings's Asset Turnover for the quarter that ended in Jun. 2023 is

	Asset Turnover
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	0	/	( (15.548	+	12.622)	/ 2 )
=	0	/	14.085
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Regencell Bioscience Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.